Literature DB >> 21637116

Comparison of retinal nerve fiber layer measurement between 2 spectral domain OCT instruments.

Benjamin B Tan1, Maricel Natividad, Kia-Chong Chua, Leonard W Yip.   

Abstract

PURPOSE: To determine the repeatability of retinal nerve fiber layer (RNFL) measurement from 2 spectral domain optical coherence tomography (OCT) instruments and assess the level of agreement. A secondary objective was to assess if pupillary dilatation affected the repeatability of RNFL measurement.
DESIGN: Prospective, observational study. PARTICIPANTS: Fifty normal participants were recruited after being screened for exclusion criteria, which included preexisting glaucoma and significant cataract.
METHODS: Peripapillary RNFL thickness was measured from either eye of the 50 participants using both the Cirrus and Spectralis OCTs. Three scans were performed consecutively for each instrument and the process was repeated after pupillary dilatation. MAIN OUTCOME MEASURES: Test-retest variability, coefficient of variation, and intraclass correlation coefficient (ICC) for repeatability of RNFL measurement. ICC and Bland-Altman plots for agreement between both devices.
RESULTS: Test-retest variability for the Cirrus and Spectralis OCTs were 4.89 μm and 4.95 μm, respectively. RNFL measurements were less repeatable in the 4 quadrants, ranging from 5.02 to 15.00 μm. The temporal quadrant was the most repeatable quadrant for the Cirrus OCT with a variability of 7.81 μm, whereas the nasal quadrant was the most repeatable for Spectralis OCT with 5.02 μm. Test-retest variability was poorer for the Cirrus OCT in the nasal, inferior, and superior quadrants. Pupillary dilatation increased repeatability of RNFL measurement for Cirrus OCT, particularly in the superior quadrant, whereas not affecting measurements from Spectralis OCT. ICC values for agreement between both instruments were good. For average RNFL as well as RNFL in the superior, inferior, and temporal quadrants, ICC ranged from 0.859 to 0.908. The nasal quadrant had a lower ICC of 0.663. Bland-Altman plots showed that the Spectralis OCT provided the thicker RNFL measurement in general, except in the nasal quadrant when RNFL was thin.
CONCLUSIONS: The repeatability of RNFL thickness measurement in normal participants was excellent for both the Cirrus and Spectralis OCTs. Agreement of RNFL measurement between both the devices was generally good, with the exception of the nasal quadrant in which a linear relationship exists. Pupillary dilatation improved the repeatability of RNFL measurement for Cirrus while having minimal influence on Spectralis OCT. More studies will be required to ascertain the relationships of RNFL measurement between the different spectral domain OCT instruments in normal and glaucomatous patients.

Entities:  

Mesh:

Year:  2012        PMID: 21637116     DOI: 10.1097/IJG.0b013e3182071cdd

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  33 in total

1.  A comparison of false positives in retinal nerve fiber layer, optic nerve head and macular ganglion cell-inner plexiform layer from two spectral-domain optical coherence tomography devices.

Authors:  Marina Leal-Fonseca; Gema Rebolleda; Noelia Oblanca; Javier Moreno-Montañes; Francisco J Muñoz-Negrete
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-12-12       Impact factor: 3.117

Review 2.  Test-retest variability in structural parameters measured with glaucoma imaging devices.

Authors:  Makoto Araie
Journal:  Jpn J Ophthalmol       Date:  2012-11-09       Impact factor: 2.447

3.  Optimizing the information yield of 3-D OCT in glaucoma.

Authors:  Henriët Springelkamp; Kyungmoo Lee; Wishal D Ramdas; Johannes R Vingerling; Albert Hofman; Caroline C W Klaver; Milan Sonka; Michael D Abràmoff; Nomdo M Jansonius
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-12-13       Impact factor: 4.799

4.  Individual A-scan signal normalization between two spectral domain optical coherence tomography devices.

Authors:  Chieh-Li Chen; Hiroshi Ishikawa; Gadi Wollstein; Yun Ling; Richard A Bilonick; Larry Kagemann; Ian A Sigal; Joel S Schuman
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-05-17       Impact factor: 4.799

5.  Associations of macular thickness in spectral-domain OCT with ocular and systemic cardiovascular parameters - the MIPH Eye & Health Study.

Authors:  Alexander Karl-Georg Schuster; Joachim Ernst Fischer; Urs Vossmerbaeumer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-09-26       Impact factor: 3.117

6.  Effect of head tilt on repeatability of optic nerve head parameters using cirrus spectral-domain optical coherence tomography.

Authors:  Lilian Hui Li Koh; Muhammad Amir Ismail; Sae Cheong Yap; Elizabeth Poh Ying Wong; Leonard Wei Leon Yip
Journal:  Int J Ophthalmol       Date:  2016-08-18       Impact factor: 1.779

7.  Testing a phantom eye under various signal-to-noise ratio conditions using eleven different OCT devices.

Authors:  Tuomas Heikka; Giovanni Ometto; Giovanni Montesano; Scott Rowe; Nomdo M Jansonius; David P Crabb
Journal:  Biomed Opt Express       Date:  2020-02-07       Impact factor: 3.732

8.  Residual and Dynamic Range of Retinal Nerve Fiber Layer Thickness in Glaucoma: Comparison of Three OCT Platforms.

Authors:  Jean-Claude Mwanza; Hanna Y Kim; Donald L Budenz; Joshua L Warren; Michael Margolis; Scott D Lawrence; Pooja D Jani; Garrett S Thompson; Richard K Lee
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-10       Impact factor: 4.799

9.  Influence of corneal power on circumpapillary retinal nerve fiber layer and optic nerve head measurements by spectral-domain optical coherence tomography.

Authors:  Kazunori Hirasawa; Nobuyuki Shoji
Journal:  Int J Ophthalmol       Date:  2017-09-18       Impact factor: 1.779

10.  Measurement Floors and Dynamic Ranges of OCT and OCT Angiography in Glaucoma.

Authors:  Sasan Moghimi; Christopher Bowd; Linda M Zangwill; Rafaella C Penteado; Kyle Hasenstab; Huiyuan Hou; Elham Ghahari; Patricia Isabel C Manalastas; James Proudfoot; Robert N Weinreb
Journal:  Ophthalmology       Date:  2019-03-08       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.